LIANYLianBio

About LianBio (LIANY)

LianBio (LIANY) is a Biotechnology company headquartered in Princeton, NJ, United States whose shares trade over-the-counter on the Pink tier.

LianBio ("LianBio" or the "Company") is a clinical stage biopharmaceutical company dedicated to bringing innovative medicines to patients with unmet medical needs in Asia. The Company was incorporated in the Cayman Islands in July 2019 and maintains its Chinese headquarters in Shanghai, China. The Company conducts its corporate activities at its United States headquarters located in Princeton, New Jersey.

Products and services

We are a clinical stage biopharmaceutical company with a pipeline of five in-licensed therapeutic candidates across oncology and inflammatory disease indications, each with its own distinct value proposition and the potential to drive new standards of care.

LIANY key facts

Ticker symbol

LIANY

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Princeton, NJ, United States

Country of incorporation

KY

Year of incorporation

2019

Employees

52

Estimated market cap

$21.97M (as of Apr 11, 2025)

Shares outstanding

109,839,415

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2023)

LianBio leadership

• Adam Stone — CEO
• Kaitlin Ortega — Vice President, Controller
• Brianne Jahn — CBO

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with L